In addition to improving CD28-mediated messaging, it was proposed that the ensuing cellular cross-linking would strengthen and prolong T cell/AML-DC contacts, thus boosting T cells’ sensitivity to AML antigens (200). Here, CD28 is linked to acute myeloid leukemia.